Main focus on small-mid cap commercial biotech with solid pipeline/platform. 👀 for substantial growth with best risk-adj returns. Long AXGN, NBIX, SUPN, CORT, NVCR, LGIH, AKAO, OMER. Oh and don't be a 🐑 😁. Vast majority cannot even beat the S&P 500.
- Member since October 26th 2017
- Equities, Growth